Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $2.18 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.